Modeling Dual Antiviral Activity of Lonafarnib to Explain Hepatitis D Virus RNA Negativity 24 Weeks after End of Therapy Despite RNA Positivity at End of Therapy: the D-LIVR Study
JOURNAL OF HEPATOLOGY(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要